Effectiveness and tolerability of programmed cell death protein-1 inhibitor + chemotherapy compared to chemotherapy for upper gastrointestinal tract cancers

doi:10.4251/wjgo.v16.i4.1613

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1189)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

101

HTML

603

Figures (1-4)

128

Tables (1-1)

145

Sum=977

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

130

Sum=168

Apr 15, 2024 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1613-1625
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1613

Full Size Figure Download Figure

Figure 2 Risk of bias of each included study. Red circles: Studies with a high risk of bias. Green circles: Studies with a low risk of bias. Yellow circles: Studies with insufficient information for assessing the risk of bias.

Citation: Zhang XM, Yang T, Xu YY, Li BZ, Shen W, Hu WQ, Yan CW, Zong L. Effectiveness and tolerability of programmed cell death protein-1 inhibitor + chemotherapy compared to chemotherapy for upper gastrointestinal tract cancers. World J Gastrointest Oncol 2024; 16(4): 1613-1625
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1613.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1613